Insight Wealth Strategies LLC Takes Position in Molina Healthcare, Inc. (NYSE:MOH)

Insight Wealth Strategies LLC purchased a new stake in shares of Molina Healthcare, Inc. (NYSE:MOH) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 4,888 shares of the company’s stock, valued at approximately $2,008,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. McIlrath & Eck LLC purchased a new stake in Molina Healthcare in the fourth quarter worth approximately $34,000. VisionPoint Advisory Group LLC boosted its holdings in Molina Healthcare by 105.6% in the third quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company’s stock worth $36,000 after purchasing an additional 57 shares during the last quarter. Raleigh Capital Management Inc. boosted its holdings in Molina Healthcare by 40.4% in the third quarter. Raleigh Capital Management Inc. now owns 125 shares of the company’s stock worth $41,000 after purchasing an additional 36 shares during the last quarter. Principal Securities Inc. purchased a new stake in Molina Healthcare in the fourth quarter worth approximately $42,000. Finally, Householder Group Estate & Retirement Specialist LLC boosted its holdings in Molina Healthcare by 3,933.3% in the fourth quarter. Householder Group Estate & Retirement Specialist LLC now owns 121 shares of the company’s stock worth $43,000 after purchasing an additional 118 shares during the last quarter. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Insider Buying and Selling at Molina Healthcare

In other Molina Healthcare news, COO James Woys sold 10,000 shares of Molina Healthcare stock in a transaction on Wednesday, May 22nd. The shares were sold at an average price of $345.15, for a total value of $3,451,500.00. Following the sale, the chief operating officer now directly owns 53,613 shares in the company, valued at approximately $18,504,526.95. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other Molina Healthcare news, COO James Woys sold 10,000 shares of Molina Healthcare stock in a transaction on Wednesday, May 22nd. The shares were sold at an average price of $345.15, for a total value of $3,451,500.00. Following the sale, the chief operating officer now directly owns 53,613 shares in the company, valued at approximately $18,504,526.95. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Ronna Romney sold 250 shares of Molina Healthcare stock in a transaction on Tuesday, May 21st. The shares were sold at an average price of $343.27, for a total transaction of $85,817.50. Following the completion of the sale, the director now owns 16,945 shares in the company, valued at $5,816,710.15. The disclosure for this sale can be found here. 1.11% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

MOH has been the topic of several research reports. Wells Fargo & Company dropped their target price on shares of Molina Healthcare from $410.00 to $375.00 and set an “equal weight” rating on the stock in a report on Monday, April 29th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $406.00 price target on shares of Molina Healthcare in a research report on Thursday, April 4th. Stephens reiterated an “equal weight” rating and issued a $390.00 price target on shares of Molina Healthcare in a research report on Thursday, April 25th. Baird R W upgraded shares of Molina Healthcare to a “strong-buy” rating in a research report on Thursday, May 30th. Finally, JPMorgan Chase & Co. decreased their price target on shares of Molina Healthcare from $435.00 to $420.00 and set an “overweight” rating on the stock in a research report on Thursday, May 30th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, Molina Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $407.45.

Molina Healthcare Price Performance

Shares of MOH stock traded down $2.17 on Wednesday, hitting $305.91. 546,535 shares of the stock traded hands, compared to its average volume of 543,431. The firm has a market cap of $17.93 billion, a price-to-earnings ratio of 16.60, a PEG ratio of 0.94 and a beta of 0.57. Molina Healthcare, Inc. has a 52 week low of $273.63 and a 52 week high of $423.92. The firm has a 50 day simple moving average of $338.19 and a two-hundred day simple moving average of $366.57. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.49 and a quick ratio of 1.49.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, April 24th. The company reported $5.73 EPS for the quarter, beating the consensus estimate of $5.46 by $0.27. The firm had revenue of $9.93 billion for the quarter, compared to the consensus estimate of $9.45 billion. Molina Healthcare had a net margin of 2.99% and a return on equity of 29.86%. The company’s revenue was up 21.9% on a year-over-year basis. During the same period last year, the firm earned $5.81 EPS. As a group, equities research analysts predict that Molina Healthcare, Inc. will post 23.56 earnings per share for the current fiscal year.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.